Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma

被引：0
|
作者：
Tamura, A. [1 ]
Yoshida, M. [2 ]
Yamamoto, N. [1 ]
Nakamura, S. [1 ]
Fujiwara, T. [1 ]
Tahara, T. [1 ]
Saito, A. [1 ]
Kozaki, A. [1 ]
Kishimoto, K. [1 ]
Ishida, T. [1 ]
Hasegawa, D. [1 ]
Kosaka, Y. [1 ]
机构：
[1] Kobe Childrens Hosp, Hematol & Oncol, Kobe, Hyogo, Japan
[2] Kobe Childrens Hosp, Dept Diagnost Pathol, Kobe, Hyogo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-538
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [21] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 220 - 220
  • [22] Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma
    Gulec, Umran Kucukgoz
    Bagir, Emine Kilic
    Paydas, Semra
    Guzel, Ahmet Baris
    Gumurdulu, Derya
    Vardar, Mehmet Ali
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 244 : 51 - 55
  • [23] Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment
    Jomrich, Gerd
    Kollmann, Dagmar
    Ramazanova, Dariga
    Ristl, Robin
    Grose, Richard P.
    Ilhan-Mutlu, Ayseguel
    Preusser, Matthias
    Fassnacht, Christina
    Tsai, Yi-Chien
    Guenova, Emmanuella
    Schoppmann, Sebastian F.
    EJSO, 2022, 48 (02): : 383 - 390
  • [24] Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms
    Chen, Chi
    Pandey, Anita
    Kundra, Ajay
    Kodali, Sreenath
    Wong, Ching
    Cheung, Tony W.
    Gotlieb, Vladimir K.
    Joseph, Gardith
    Tribie, Sophia
    Wang, Jen-Chin
    BLOOD, 2018, 132
  • [25] Prognostic Impact of Programmed Cell Death-1 (PD-1) and PD-Ligand 1 (PD-L1) Expression in Thymic Cancer
    Funaki, S.
    Shintani, Y.
    Ose, N.
    Kawamura, T.
    Kanzaki, R.
    Minami, M.
    Okumura, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2064 - S2065
  • [26] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Guzel, A. B.
    Khatib, G.
    Seydaoglu, G.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1126 - 1126
  • [27] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    Tatiana Salles de Souza Malaspina
    Thaís Helena Gasparoto
    Maria Renata Sales Nogueira Costa
    Edgard Franco de Melo
    Maura Rosane Valério Ikoma
    José Humberto Damante
    Karen Angélica Cavassani
    Gustavo Pompermaier Garlet
    João Santana da Silva
    Ana Paula Campanelli
    Cancer Immunology, Immunotherapy, 2011, 60 : 965 - 974
  • [28] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    de Souza Malaspina, Tatiana Salles
    Gasparoto, Thais Helena
    Sales Nogueira Costa, Maria Renata
    de Melo, Edgard Franco, Jr.
    Valerio Ikoma, Maura Rosane
    Damante, Jose Humberto
    Cavassani, Karen Angelica
    Garlet, Gustavo Pompermaier
    da Silva, Joao Santana
    Campanelli, Ana Paula
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 965 - 974
  • [29] Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
    Guan, Jian
    Lim, Khin Sandar
    Mekhail, Tarek
    Chang, Chung-Che
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 851 - 861
  • [30] Programmed Cell Death Ligand 1 (PD-L1) Expression in Pancreatic Ductal Adenocarcinoma
    Sheffield, Brandon S.
    Kalloger, Steve E.
    Milne, Katy
    Nelson, Brad H.
    Renouf, Daniel
    Schaeffer, David F.
    MODERN PATHOLOGY, 2016, 29 : 200A - 200A
12345